Puma Biotechnology PBYI
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$1.43M (8 inflow days, 12 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 37.9% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 8.07% to 8.33% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| American Century Investment Management | Mutual Fund | 2026/Q3 | +422,657 | 5.3% |
| BlackRock | Mutual Fund | 2026/Q3 | +402,445 | 8.1% |
| LSV Asset Management | Mutual Fund | 2026/Q3 | +323,120 | 3.8% |
| Morgan Stanley | Public Company | 2026/Q3 | +165,918 | 0.8% |
| Morgan Stanley Investment Management Inc. | Mutual Fund | 2026/Q3 | +165,918 | 0.8% |
| SummerHaven Investment Management, LLC | Mutual Fund | 2026/Q3 | +114,315 | 0.2% |
| Federated Hermes, Inc. | Mutual Fund | 2026/Q3 | +84,867 | 0.6% |
| Legato Capital Management, LLC | Mutual Fund | 2026/Q3 | +83,190 | 0.2% |
| Los Angeles Capital Management LLC | Mutual Fund | 2026/Q3 | +81,019 | 0.2% |
| Vanguard Portfolio Management, LLC | Mutual Fund | 2026/Q3 | +67,680 | 3.7% |
| OpenArc Corporate Advisory, LLC | Family Office/Trust | 2026/Q3 | +60,133 | 0.2% |
| FMR | Mutual Fund | 2026/Q3 | +55,734 | 0.5% |
| Renaissance Technologies Corp. | Hedge Fund | 2026/Q3 | +47,800 | 3.6% |
| First Trust Advisors L.P. | Mutual Fund | 2026/Q3 | +42,421 | 0.3% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +59,119 | 0.1% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 10 Nov 2026 | Michael Miller | Independent Director | Intent to Sell (Form 144) | -15,000 | $8.10 | – |
| 13 Sep 2026 | Troy Wilson | Independent Director | Open Market Disposition | -5,000 | $9.10 | 28,300 |
| 13 Sep 2026 | Alessandra Cesano | Independent Director | Open Market Disposition | -12,150 | $9.12 | 29,700 |
| 13 Sep 2026 | Alessandra Cesano | Independent Director | Derivative Exercise and Sale | -50,000 | $9.12 | 29,700 |
| 5 Jul 2026 | Alan Auerbach | Founder, Chairman, President, CEO & Secretary | Automatic Disposition | -44,058 | $8.26 | 7,092,238 |
| 5 Jul 2026 | Douglas Hunt | Chief Regulatory Affairs, Medical Affairs, Pharmacovigilance & Law Officer | Automatic Disposition | -8,460 | $8.26 | 147,766 |
| 5 Jul 2026 | Maximo Nougues | Chief Financial Officer | Automatic Disposition | -9,386 | $8.26 | 180,219 |
| 11 Jun 2026 | Jay Moyes | Lead Independent Director | Automatic Disposition | -22,000 | $7.22 | 31,322 |
| 11 Jun 2026 | Troy Wilson | Independent Director | Automatic Disposition | -10,800 | $7.20 | 33,300 |
| 11 Jun 2026 | Adrian Senderowicz | Independent Director | Automatic Disposition | -27,000 | $7.20 | – |
| 11 Jun 2026 | Allison Dorval | Independent Director | Automatic Disposition | -11,610 | $7.20 | 63,780 |
| 11 Jun 2026 | Brian Stuglik | Independent Director | Automatic Disposition | -8,100 | $7.20 | 86,858 |
| 10 Jun 2026 | Jay Moyes | Lead Independent Director | Other Acquisition | +27,000 | – | 27,000 |
| 10 Jun 2026 | Michael Miller | Independent Director | Other Acquisition | +27,000 | – | 27,000 |
| 10 Jun 2026 | Troy Wilson | Independent Director | Other Acquisition | +27,000 | – | 27,000 |
| 10 Jun 2026 | Alessandra Cesano | Independent Director | Other Acquisition | +27,000 | – | 27,000 |
| 10 Jun 2026 | Adrian Senderowicz | Independent Director | Other Acquisition | +27,000 | – | 27,000 |
| 10 Jun 2026 | Allison Dorval | Independent Director | Other Acquisition | +27,000 | – | 27,000 |
| 10 Jun 2026 | Brian Stuglik | Independent Director | Other Acquisition | +27,000 | – | 27,000 |
| 17 Feb 2026 | Alan Auerbach | Founder, Chairman, President, CEO & Secretary | Other Acquisition | +159,778 | – | 258,978 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 4,298,038 | 8.3% | 11.5 |
| 15 Oct 2026 | 4,540,314 | 8.8% | 12.9 |
| 30 Sep 2026 | 4,264,923 | 8.3% | 14.0 |
| 15 Sep 2026 | 4,319,663 | 8.4% | 13.8 |
| 31 Aug 2026 | 4,274,524 | 8.3% | 15.6 |
| 14 Aug 2026 | 4,167,830 | 8.1% | 11.4 |
No comments yet — be the first to weigh in on PBYI.
Sign in to join the discussion.